A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

John Koreth, Haesook T. Kim, Paulina B. Lange, Bhavjot Bindra, Carol G. Reynolds, Marie J. Chammas, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Sarah Nikiforow, Jerome Ritz, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences